Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial
- Charles B. Nguyen
- , Melissa A. Reimers
- , Chamila Perera
- , Wassim Abida
- , Jonathan Chou
- , Felix Y. Feng
- , Emmanuel S. Antonarakis
- , Rana R. McKay
- , Russell K. Pachynski
- , Jingsong Zhang
- , Zachery R. Reichert
- , Phillip L. Palmbos
- , Megan E.V. Caram
- , Ulka N. Vaishampayan
- , Elisabeth I. Heath
- , Alexander C. Hopkins
- , Marcin P. Cieslik
- , Yi Mi Wu
- , Dan R. Robinson
- , Veerabhadran Baladandayuthapani
- Section of Medical Oncology
- Institute of Clinical and Translational Sciences (ICTS)
- Bursky Center for Human Immunology and Immunotherapy
- Siteman Cancer Center
- Section of Molecular Oncology & Developmental Therapeutics
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- DBBS - Cancer Biology
- DBBS - Immunology
- DBBS - Molecular Cell Biology
- Mentorship to Enhance Development in Academia Program
Research output: Contribution to journal › Article › peer-review
37
Link opens in a new tab
Scopus
citations